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We have used complementary biochemical and in vivo approaches to study the compartmental-
ization of M phase-promoting factor (MPF) in prophase Xenopus eggs and oocytes. We first
examined the distribution of MPF (Cdc2/CyclinB2) and membranous organelles in high-speed
extracts of Xenopus eggs made during mitotic prophase. These extracts were found to lack
mitochondria, Golgi membranes, and most endoplasmic reticulum (ER) but to contain the bulk of
the pre-MPF pool. This pre-MPF could be pelleted by further centrifugation along with compo-
nents necessary to activate it. On activation, Cdc2/CyclinB2 moved into the soluble fraction.
Electron microscopy and Western blot analysis showed that the pre-MPF pellet contained a
specific ER subdomain comprising “annulate lamellae” (AL): stacked ER membranes highly
enriched in nuclear pores. Colocalization of pre-MPF with AL was demonstrated by anti-CyclinB2
immunofluorescence in prophase oocytes, in which AL are positioned close to the vegetal surface.
Green fluorescent protein-CyclinB2 expressed in oocytes also localized at AL. These data suggest
that inactive MPF associates with nuclear envelope components just before activation. This
association may explain why nuclei and centrosomes stimulate MPF activation and provide a
mechanism for targeting of MPF to some of its key substrates.
INTRODUCTION
The structural changes accompanying mitosis and meiosis
are governed in almost all species by M phase-promoting
factor (MPF) (Masui and Markert, 1971), a complex of Cyclin
B and the kinase Cdc2 (reviewed in Nigg, 1995; Morgan,
1997). Direct and indirect targets for MPF include the nu-
clear envelope and lamina, chromatin proteins, and regula-
tors of mitotic spindle formation (Moreno and Nurse, 1990;
Norbury and Nurse, 1992). MPF activation requires the con-
tinuous synthesis and accumulation during interphase of
Cyclin B, which binds Cdc2 to form inactive pre-MPF. Pre-
MPF is maintained inactive by inhibitory phosphorylation
on Cdc2 by the Wee1 and Myt1 kinases. At the onset of
mitosis, rapid MPF activation is favored by a positive feed-
back loop involving Cdc25 phosphatases, MPF itself, and
Polo-like kinases. Degradation of Cyclin B at the metaphase-
to-anaphase transition by the anaphase promoting complex
(APC) destroys the MPF complex and causes exit from mi-
tosis (reviewed in Nurse, 1990; Whitaker and Patel., 1990;
Norbury and Nurse, 1992; Nigg, 1995; Morgan, 1997, 1999;
Beckhelling and Ford, 1998; O’Farrell, 2001).
Amphibian eggs have proved extremely useful for the
study of MPF regulation. Cycles of Cyclin B accumulation
and destruction sufficient to drive synchronous cell cycles in
the absence of any other protein synthesis occur in both
fertilized or activated eggs and in egg extracts (Murray and
Kirschner, 1989; Murray et al., 1989; Hartley et al., 1996).
Although MPF activation cycles in amphibian oocytes and
eggs can continue in the absence of nuclei and microtubules
(Hara et al., 1980; Shinagawa, 1983; Gerhart et al., 1984;
Newport and Kirschner, 1984; Kimelman et al., 1987; Shina-
gawa, 1992), two lines of evidence have demonstrated that
subcellular structure is important for MPF activation, even
in cytoplasmic extracts. First, nuclei, centrosomes and mi-
crotubules have all been shown to stimulate MPF activation
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both in manipulated cells and extracts (Detlaff et al., 1964
and references therein, Gautier, 1987; Iwashita et al., 1998;
Pe´rez-Mongiovi et al., 2000). Second, M-phase entry and exit
proceed inhomogeneously within the cell (Masui, 1972; Iwao
and Elinson, 1990) and travel as waves from the animal
hemisphere, where the nucleus and centrosomes are located,
to the vegetal hemisphere (Rankin and Kirschner, 1997;
Pe´rez-Mongiovi et al., 1998). Such observations have led to
the suggestion that the nuclear-centrosomal region serves to
accumulate MPF and/or its regulators to achieve locally a
threshold level that would seed the initial activation of
mitosis (Cyert and Kirschner, 1988; Novak and Tyson, 1993;
Beckhelling et al., 2000; De Souza et al., 2000). A number of
localization studies concerning MPF and its regulators per-
formed in a variety of cell types are consistent with this
possibility. B Cyclins, Cdc25, Polo kinase, Wee1, and Myt1
have all been found to localize to structures such as
prophase microtubule asters, centrosomes, nuclei, endoplas-
mic reticulum (ER), and Golgi, their associations with these
structures varying with cell cycle time and activity of the
molecules involved (Bailly et al., 1989, 1992; Jackman et al.,
1995; Liu et al., 1997; Sakamoto et al., 1998; Ashcroft et al.,
1999; Ohi and Gould, 1999; Pines, 1999; Charrasse et al., 2000;
Takizawa and Morgan, 2000).
Very little is known about the subcellular localization of
MPF and its regulators in amphibian eggs. Their large size
and yolky cytoplasm severely hampers light microscopy
techniques, especially in the deep, nuclear region. We have
approached this question by analyzing the distribution of
MPF in extracts of prophase eggs fractionated by centrifu-
gation. By prophase, progression through mitosis is com-
pletely dependent upon posttranslational changes to the
pre-MPF complex because CyclinB has accumulated above
the levels required for activation. We focused our analysis
on a fraction from prophase Xenopus egg extracts previously
shown to be necessary for MPF activation (Felix et al., 1989).
We found that inactive MPF and inactive Cdc25 were con-
centrated in this fraction, whereas the active forms of these
enzymes were soluble. Electron microscopy (EM) and West-
ern blot analysis unexpectedly revealed that a distinctive ER
subpopulation rich in nuclear pores (annulate lamellae, AL),
cosedimented with the pre-MPF. This observation led us to
explore the localization of pre-MPF with respect to AL in
fixed oocytes by immunofluorescence and in live oocytes by
CyclinB2-green fluorescent protein (GFP) imaging.
MATERIALS AND METHODS
Antibodies and Reagents
Primary antibodies were as follows: anti-PSTAIR monoclonal anti-
body (mAb) (Sigma-Aldrich, St. Louis, MO); affinity purified anti-
Xenopus CyclinB2 antibody from rabbit serum (provided by M.
Dore´e, Center de Recherches de Biochimie Macromoleculaire,
Montpellier, France); rabbit anti-Xenopus Cdc25C polyclonal anti-
body (provided by E. Shibuya, University of Alberta, Edmonton,
Canada); anti-GRP94 rat mAb (StressGen Biotechnologies, Victoria,
British Columbia, Canada) used as an ER marker (Argon and Simen,
1999; Brunati et al., 2000); and anti-human mitochondrial voltage
dependent anion channel (VDAC) polyclonal rabbit antibody raised
against CSPNTGKKNAKIKTGYKREH (provided by M. Colombini,
Department of Biology, University of Maryland, College Park, MD)
used as a mitochondrial marker. Nuclear pore proteins were de-
tected with anti-Nup mAb, QE5 (Eurogentec, Seriang, Belgium),
and anti--tubulin with mAb GTU-88 (Sigma-Aldrich). Golgi mark-
ers were anti-syntaxin and GS15 (BD Biosciences, Erembodegem,
Belgium). 1,2-Bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic
acid (BAPTA) (Calbiochem, San Diego, CA) was dissolved at 250
mM in water and neutralized to pH 7.0 with concentrated HCl.
Cytochalasin B was stored as a stock solution of 10 mg/ml in
dimethyl sulfoxide (DMSO). Stocks of aprotinin and leupeptin were
stored at 10 mg/ml in water, pepstatin at 5 mg/ml in DMSO, and
4-(2-aminoethyl)benzenesulfonyl fluoride at 0.2 M in water. All
other reagents were from Sigma-Aldrich unless otherwise stated.
Extracts and Centrifugation
Female Xenopus laevis (Center National de la Recherche Scientifique
Rennes, France; Horst Ka¨hler, Hamburg, Germany; or Blades Bio-
logical, Cowden, England), preinjected in some experiments with 50
IU of pregnant mare serum, were induced to ovulate by injection of
750 IU of human chorionic gonadotropin (Organon Teknika, West
Chester, PA). Eggs were laid into high salt water (110 mM NaCl in
stored tap water at 21°C). The jelly coat was removed using a
solution containing 110 mM NaCl, 20 mM Tris pH 8.5, 5 mM
dithiothreitol (DTT). Eggs were then washed gently three times in
Barth X [110 mM NaCl, 10 mM HEPES, 2.4 mM NaHCO3, 1 mM
KCl, 0.8 mM MgSO4, 0.4 mM CaCl2, 0.33 mM Ca(NO3)2, pH 7.6].
Necrotic or activated eggs were removed.
Preparation and fractionation of extracts were based on a protocol
devised by Felix et al., (1989) with the modifications of Lindsay et al.
(1995). The protocol is summarized in Figure 1. Eggs were activated
in glass dishes with ionophore A23187 at a final concentration of 0.1
g/ml. Ionophore was diluted from a stock solution of 1 mg/ml (in
DMSO) into 50 ml of 25% (vol/vol) Barth X. Eggs were left in
ionophore solution for 2 min and then washed with two changes of
25% (vol/vol) Barth X. Activated eggs from two to four females
(5–15 ml of eggs) were incubated at 21°C for 55–60 min and then
transferred to a 50-ml tube and washed twice in ice cold extraction
buffer (EB, 100 mM K-acetate, 2.5 mM Mg-acetate, 1 mM DTT, 20
mM HEPES pH 7.2, 250 mM sucrose). Eggs were transferred to a
minimal volume of ice cold extraction buffer containing 2.5 mM
1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid, 5 g/ml
cytochalasin B, and protease inhibitors (10 g/ml aprotinin, 10
g/ml leupeptin, 0.76 mM 4-(2-aminoethyl)benzenesulfonyl fluo-
ride, 15 g/ml pepstatin) in 5-ml plastic centrifuge tubes and
packed by centrifugation at 700 rpm in a Jouan CR 4-11 centrifuge.
Excess buffer was removed. The eggs were then centrifuged at
12,000 rpm (10,000  g) for 12 min at 4°C in a Beckman Coulter
L8-55 M ultracentrifuge (rotor SW55). The low-speed supernatant
(LSS) between the lipid cap and the pigment/yolk pellet was re-
moved with a cold Pasteur pipette or by side puncturing the tube
with a syringe and wide bore needle. The LSS was centrifuged at
48,000 rpm (245,000  g) for 2 h at 4°C in 5-ml tubes if sufficient
volume, otherwise in 0.6-ml tubes with adapters in the SW55 rotor.
The resultant high-speed supernatant (HSS) was removed by side
puncture of the tube with a syringe and wide gauge needle. At least
three distinct layers of high-speed pellet were distinguishable: a
dense orange pellet, presumed to be glycogen (Meier et al., 1995)
overlain successively by a dark brown pellet (HSP-1a) and a yellow
layer (HSP-1b). HSP-1a and -1b were removed with wide-mouthed
pipette tips and swirled into EB containing protease inhibitors in
5-ml centrifuge tubes. These were then recentrifuged at 20,000 rpm for
20 min at 4°C in the SW55 rotor. After this washing step, each pellet
was combined with an equal volume of 60% (wt/vol) sucrose (in EB
containing protease inhibitors) and snap frozen in 5-l aliquots in
liquid nitrogen. Aliquots (50 l) of HSS were also snap frozen.
To fractionate the HSS-1 further, it was mixed with an equal volume
of ice-cold extraction buffer containing protease inhibitors and “energy
mix” (1 l/50 l of extract): 500 mM creatine phosphate, 4 mg/ml
creatine phosphokinase (in 50% glycerol [vol/vol] in H2O), and 50 mM
ATP (pH 7.0 in 20 mM HEPES). After mixing, 2 ml of diluted super-
natant were transferred to 3-ml thick-walled polycarbonate tubes and
C. Beckhelling et al.
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centrifuged at 68,000 rpm (275,000 g) at 4°C for 1 h 45 min in a fixed
angle rotor (TLA100.3) in a TL100 tabletop centrifuge. The resultant
ultrahigh-speed supernatant (HSS-2) and an ultrahigh-speed pellet
(HSP-2) were separated by removing the supernatant with a Pasteur
pipette. HSP-2 consisted of a lighter “fluffy” part and a viscous part.
The supernatant was removed carefully by pipetting up to the “fluffy”
part of the pellet. This routinely left100 l of supernatant and pellet,
which were then mixed to resuspend both parts of the pellet with a
wide-mouthed pipette tip. HSP-2 was diluted 1:1 with 60% (wt/vol)
sucrose (in EB containing protease inhibitors) before snap freezing as
5-l aliquots in liquid nitrogen. HSS-2 was snap frozen as 10- or 100-l
aliquots. Average protein concentrations of the fractions were deter-
mined by standard Bradford assay (Bio-Rad, Hercules, CA) and were
as follows: 30–40 mg/ml HSS-1, 40–50 mg/ml HSP-1a, 40–50 mg/ml
HSP-1b, 10–25 mg/ml HSS-2, and 40–50 mg/ml HSP-2.
SDS-PAGE and Western Blotting
Each extract fraction was combined on thawing with 1 volume of
water and 6 volumes of 2 SDS sample buffer (Laemmli, 1970)
except HSS-2, which was combined with 3 volumes of 2 SDS
sample buffer. Samples were boiled for 4 min before loading 20 g
of protein onto SDS-polyacrylamide gels: 8% for Nup, 10% for
Cdc25/CyclinB2/PSTAIRE, and 12% for GRP94/VDAC. Electro-
phoresis was performed for 3–4 h at 100 V with a maximum of 250
mA in running buffer (0.1% SDS, 0.025 M Tris, 0.192 M glycine;
Laemmli, 1970).
Transfers onto nitrocellulose paper (Shleicher & Schuell, Keene,
NH) were carried out in 0.025 M Tris/0.192 M glycine/15% meth-
anol at 100 V for 60 min. For immunodetection, the protocol was
exactly as in Pe´rez-Mongiovi et al., (2000). Primary antibodies were
Cdc25, 1/2000; CyclinB2, 1:500; PSTAIRE, 1:2000; GRP94, 1:2000;
VDAC, 1:2000; and Nup, 1:500.
Electron Microscopy
Samples (not 50 l) for thin sectioning were diluted 50-fold into
phosphate-buffered saline (PBS) containing 0.1 M sucrose, 2% glu-
taraldehyde, and 2% osmium tetroxide for 30 min on ice, before
pelleting at 4000 rpm in a Jouan CR 4-11 centrifuge at 4°C for 10
min. The pellets were washed in PBS/sucrose before dehydration in
a graded series of ethanol (50, 60, 70, 80, 90, 95, and 3  100%). The
pellets were embedded in Spurr’s resin and baked at 70°C over-
night. Silver sections cut from the blocks were poststained on grids
with 2% uranyl acetate followed by lead citrate. Micrographs were
taken with a Hitachi H-600 electron microscope. Negative staining
was carried out according to the protocol of Meier et al. (1995) with
modifications. A 10-l sample of unfixed HSP-2 was washed in 50
l of ice-cold wash buffer (10 mM HEPES pH 7.4, 3 mM MgCl2
containing protease inhibitors as for EB; see above) in a 1.5-ml
Eppendorf tube and centrifuged in a benchtop centrifuge at 4°C for
5 min at 14,000 rpm. The pelleted material (4 l) was deposited onto
a glow discharged pioloform-coated grid washed briefly with H2O
and then placed face down into a drop of 2% uranyl acetate for 1
min, blotted dry, and immediately observed in the electron micro-
scope as described above.
Histone Kinase Assays
HSS-1 was rapidly thawed and supplemented with energy mix as
described above. For HSS-2 and HSP-2, no further energy was
added. HSP-2 was pipetted with a wide-mouthed pipette tip and
generally 3 l of HSP-2 was combined with either 27 l of HSS-2 or
extraction buffer (containing energy as described above) for incu-
bation purposes. Aliquots (30 l) of extracts were transferred to
21°C and 2 l was removed every 10 min, diluted 1/25 in ice-cold
histone kinase buffer (80 mM -glycerophosphate, 20 mM EGTA, 15
mM MgCl2, 1 mM DTT pH 7.3, 10 g/ml aprotinin, 10 g/ml
leupeptin), and frozen in liquid nitrogen before storing at 80°C.
Histone (H1) kinase assays were carried out as described previously
(Beckhelling et al., 1999).
Immunofluorescence and Confocal Microscopy
Oocytes were fixed at 20°C in methanol containing 1% formalde-
hyde for a minimum of 2 h. After stepwise rehydration to PBS
containing 0.05% Triton X-100 at room temperature, oocytes were
extracted for 15 min in PBS/0.25% Triton X-100, rinsed in PBS, and
blocked for 1 h in 2% bovine serum albumin/PBS. Oocytes were
incubated in 50 l of the following primary antibodies: rat mAb
GRP94 at 1/500; mouse mAb NUP at 1/500; and rabbit polyclonal
antibody CyclinB2 at 1/50 overnight at 4°C to detect ER, AL, and
associated molecules. Oocytes were washed at least three times in
PBS/0.1% Tween 20 before incubation in either rhodamine (at 1/75)
and/or fluorescein isothiocyanate-labeled (at 1/100) secondary an-
tibodies (Jackson Immunoresearch Laboratories, West Grove, PA) at
room temperature for 2 h and mounted in Citifluor (Department of
Chemistry, University of Kent, Kent, United Kingdom) after repeat-
ing the washing step. Confocal images were acquired on an inverted
Figure 1. Preparation of high-speed fractions of egg extracts. Eggs,
taken 60 min after activation, were subject to a brief packing spin
before low-speed centrifugation to crush them, separating supernatant
(LSS) from yolk pellet and lipid layer. High-speed centrifugation strat-
ified supernatant (HSS-1) from differently colored pellet fractions
(HSP-1a, HSP-1b) above a gelatinous orange layer that was discarded.
Dilution and further centrifugation of HSS-1 generated HSS-2 and
HSP-2. See MATERIALS AND METHODS for detailed explanation.
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Leica SP2 confocal microscope equipped with Argon and Green
neon lasers and associated software and subsequently processed
using NIH Image software. Controls in which primary antibodies
were omitted confirmed that no cross-reaction between antibodies
occurred.
Synthesis and Microinjection of GFP and GFP-
CyclinB2 RNA
Xenopus CyclinB2 was obtained from M. Dore´e and inserted into
plasmid CS2-GFP (such that the GFP sequence was at the C terminal
of CyclinB2) containing the S65T variant of GFP with linker se-
quence AHRL (Heim et al., 1995). A nonconjugated GFP mRNA was
transcribed from the RN3-GFP plasmid (Zernicka-Goetz et al., 1996).
mRNA coding for the GFP or GFP-CyclinB2 constructs were made
using mMessage mMachine kit (Ambion, Austin, TX), purified in a
ProbeQuant kit (Amersham Biosciences, Piscataway, NJ) and stored
in diethyl pyrocarbonate-treated H2O at 80°C.
Pieces of Xenopus ovary were rotary shaken in collagenase B (1
mg/ml) in Na2HPO4 (100 mM), pH 7.4, for 30 min before transfer-
ring to OR2 (2.5 mM KCl, 82 mM NaCl, 50 mM HEPES, 10 mM
Na2HPO4, 1 mM CaCl2, 1 mM MgCl2) for manual defolliculation of
the stage VI oocytes (Dumont, 1972). Oocytes were cultured over-
night in 50% Leibowitz solution containing penicillin (10 U/ml),
streptamycin (0.01 mg/ml), gentamicin (0.1 mg/ml), and bovine
serum albumin (1 mg/ml; Euromedex, Souffelweyersheim, France)
and then were injected with 16 nl of RNA by using a Drummond
Nanoject to deliver a final amount of 4.2 ng of CyclinB2-GFP
mRNA or 5.3 ng of GFP mRNA. Oocytes were mounted in cham-
bers consisting of a glass slide and coverslip separated by a silicone
rubber spacer at various times after injection for observation of
fluorescence beneath the vegetal surface by using the confocal mi-
croscope as described above.
RESULTS
A Fraction Pelleted from High-Speed Supernatants
Is Necessary for MPF Activation
HSS of Xenopus eggs made at prophase spontaneously un-
dergo one cycle of MPF activation and inactivation (mea-
sured by histone H1 kinase activity), when incubated at
21°C. Dilution and recentrifugation of the HSS produce a
particulate fraction that is absolutely required for MPF acti-
vation (Felix et al., 1989). We have analyzed the structural
composition and partitioning of MPF in fractions prepared
by an equivalent protocol (Figure 1). High-speed centrifu-
gation of crushed egg supernatant (LSS; Figure 1), prepared
60 min after egg activation, produced dark brown (HSP-1a)
and yellow (HSP-1b) pellet fractions and supernatant
(HSS-1) that, on dilution and further centrifugation, gener-
ated a final supernatant (HSS-2) and the second high-speed
pellet (HSP-2) necessary for MPF activation.
Most HSS-1 preparations prepared 60 min after activation
displayed a cycle of MPF activation and inactivation (mon-
itored as histone H1 kinase activity). All of these could be
fractionated into HSS-2 and HSP-2 that alone were insuffi-
cient for MPF activity but when recombined mirrored H1
kinase activity of the HSS-1 (Figure 2A; Felix et al., 1989),
albeit with a lower total level of activity due to the twofold
dilution. In contrast, the HSP-1a and HSP-1b pellets could
not substitute for HSP-2 to promote H1 kinase activity when
combined with HSS-2 in most experiments (Figure 2B). In
some extracts, these pellets did permit a rise in MPF activity
when combined with HSS-2 but never to the same high
levels as those of the HSP-2/HSS-2 combination. Given the
different ability of these fractions to support MPF activation,
we went on to compare their composition first in terms of
membranous organelles and second of MPF regulatory mol-
ecules.
HSP-2 Is Enriched in Nuclear Pore Proteins and
Annulate Lammellae
Western blots using antibodies recognizing different intra-
cellular compartments (Figure 3, A–D) in parallel with trans-
mission electron microscopy (TEM) analysis (Figure 4, A–D)
revealed a distinct separation of organelles between each of
the pelleted fractions. The HSP-1a was found to contain the
bulk of the mitochondria. The mitochondrial VDAC (Xu et
Figure 2. Histone (H1) kinase
activity of fractions incubated
separately and in combination.
Samples of each fraction were
either diluted into extraction
buffer or combined with HSS-2
before transfer to 21°C. Aliquots
were taken every 10 min for up
to 80 min for assay of histone
(H1) kinase activity, expressed
as picomoles of phosphate trans-
ferred per minute per microliter
of extract. (A) HSS-2 alone (open
squares), HSP-2 alone (green tri-
angles), and HSS-2 recombined
with HSP-2 (blue circles). Nei-
ther fraction can activate H1 ki-
nase alone but when recom-
bined stimulate one cycle of
activation and inactivation of
H1 kinase. (B) From a different
extract, HSS-2 was recombined
with either HSP-2 (blue circles), HSP-1a (brown circles), or HSP-1b (yellow triangles). Only HSP-2 stimulated one cycle of mitotic
histone (H1) kinase activation and inactivation when combined with HSS-2.
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al., 1999) was detected exclusively in this fraction (Figure 3C,
lane 3). TEM analysis of fixed and sectioned pellets con-
firmed that HSP-1a contained high concentrations of mito-
chondria with some ribosomal-sized particles (Figure 4A).
The HSP-1b contained the bulk of the ER luminal protein
GRP94 (Argon and Simen, 1999) (Figure 3A, lane 2) and
contained filamentous strands associated with numerous
ribosomal-sized particles consistent with the characteristics
of rough ER (Figure 4B). Two Golgi markers (syntaxin and
GS15) distributed approximately equally between the
HSP-1a and HSP-1b but were absent from other fractions
(our unpublished data).
HSP-2, the fraction necessary for MPF activation, was
found by TEM to contain abundant granular material as well
as stacks of membranes (Figure 4C). These stacks consisted
of double membranes interrupted by regular breaks charac-
teristic of AL, a specialized region of the ER containing a
high density of nuclear pore complexes. Pores were ob-
served as holes at regular intervals crossing the membranes
in regions where membrane stacks were sectioned trans-
versely and as annuli when sectioned tangentially. The pres-
ence of pore complexes in the HSP-2 in a second extract was
confirmed by negative staining (Figure 4D). The observed
ring structures were 90 nm in diameter, falling within the
85- to 120-nm range reported for pore complexes (Kessel,
1992). The presence of nuclear membrane components in
HSP-2 was confirmed by Western blotting with a mAb gen-
erated against rat liver nuclear envelope proteins (Pante et
al., 1994) (Figure 3D, lane 5). This antibody recognizes at
least three major nuclear pore proteins: NUP214 located on
the cytoplasmic filaments of the nuclear pore complex;
NUP153 situated on the terminal ring of the nucleoplasmic
basket; and, p62, which localizes to the inner ring of the pore
(Pante et al., 1994). All three NUP proteins were strikingly
enriched in HSP-2 (Figure 3D, lane 5), although p62 was
found in variable amounts in all fractions (compare lanes
1–4). The HSP-2 was also enriched in -tubulin (Figure 3B).
Taken together, the immunodetection and EM results in-
dicate that the first high-speed centrifugation pellets the
majority of the mitochondria, Golgi, and ER from the ex-
tracts, while stratifying them into HSP-1a and HSP-1b, re-
spectively. A subfraction of the ER enriched in nuclear en-
velope components is retained in the first HSS but is then
pelleted by the second high-speed centrifugation after
dilution. Granular material that may contain proteinaceous
complexes, including -tubulin ring complexes, is also pel-
leted upon further dilution and centrifugation.
Compartmentalisation of Active and Inactive
Cdc25C and MPF
We examined the distribution of MPF regulatory molecules
in the various extract fractions on Western blots in three
different ways. First, we analyzed the distribution of these
molecules and their different isoforms in an unfractionated
LSS and among the separated fractions (Figure 5A). We then
followed a time course of the behavior of Cdc25C and Cy-
clinB2 in aliquots of HSS-2 and HSP-2 incubated at 21°C
separately and recombined (Figure 5B). Finally, we com-
pared the partitioning of activating isoforms of Cdc25C and
CyclinB2 between the HSS-2 and HSP-2 in different extracts,
which were prepared at slightly different times during the
MPF activation process (Figure 5C). Figure 5A shows an
experiment in which equal amounts of protein from each
fraction were loaded onto gels and immunoblotted by using
antibodies that recognize Cdc25C, CyclinB2, and Cdc2
(PSTAIR antibody). A striking compartmentalization of ac-
tive and inactive forms of MPF and Cdc25C was observed
between the high-speed fractions, recognizable as changes in
electrophoretic mobility caused by the different regulatory
phosphorylations. Cdc25C is hyperphosphorylated when
active and migrates distinctly higher on gels than the un-
phosphorylated inactive form. In contrast, the phosphory-
lated (upper) isoforms of Cdc2 are inactive and dephosphor-
ylation leading to activation causes a shift to a lower band.
Abundant monomeric inactive Cdc2 also migrates in the
lower band (Edgar et al., 1994; Pe´rez-Mongiovi et al., 2000).
Because our extracts were made at a time corresponding to
the beginning of mitosis, most CyclinB is nonphosphory-
lated and present in the inactive pre-MPF complex, contain-
ing inactive phosphorylated Cdc2. CyclinB is intraphospho-
rylated by activated Cdc2/CyclinB (Borgne et al., 1999) and
the appearance of the upper form of CyclinB2 has been
shown to strictly correlate with GVBD/metaphase in matur-
ing Xenopus oocytes (Kobayashi et al., 1991). The appearance
of the phosphorylated (upper) form can be considered to be
a marker of MPF activation.
After initial centrifugation of the LSS (lane 1) most
Cdc25C, CyclinB2, and Cdc2 remained in the first high-
speed supernatant (HSS-1, lanes 2 and 3). In comparison,
relatively little Cdc2/CyclinB or Cdc25C was found associ-
ated with either ER- (HSP-1B, lane 4) or mitochondrial (HSP-
1a, lane 5)-enriched pellets, although the mitochondrial frac-
tion seemed to contain some distinct Cdc25 isoforms.
Figure 3. Enrichment of nuclear pore proteins in HSP-2. Twenty
micrograms (as determined by Bradford assay) of each fraction
obtained by serial centrifugation of prophase extracts (Figure 1) was
loaded onto different percentages of gels depending upon the anti-
body to be used, transferred to nitrocellulose, and probed with the
antibodies indicated. HSP-1b was highly enriched in ER protein,
GRP94 (A, lane 2), whereas HSP-1a was enriched in the mitochon-
drial protein VDAC (C, lane 3). HSP-2 contained three nuclear pore
proteins detected by the anti-NUP antibody: NUP214, NUP153, and
p62 (arrowheads in D, lane 5). HSP-2 was also enriched in -tubulin
(B, lane 5). In all immunoblots, lane 1 contains an unfractionated
HSS-1 and lane 4 contains the HSS-2 made by dilution and recen-
trifugation of HSS-1.
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Two important observations were made after fraction-
ation of HSS-1. First, the majority of the CyclinB2, along with
inactive isoforms of Cdc25C and the inactive (phosphorylat-
ed upper) form of Cdc2 pelleted in the HSP-2 (lane7). The
presence of all the detectable inhibitorily phosphorylated
Cdc2 in this pellet infers that the majority of pre-MPF,
consisting of inactive Cdc2 bound to both major egg B
cyclins (B1 and B2), sediments in this fraction. Second, the
HSS-2 (lane 6) contained the activated isoforms of Cdc25C,
along with Cdc2 as active and/or nonphosphorylated iso-
forms, and variable amounts of phosphorylated CyclinB2,
indicative of active MPF. These observations indicate that
although the majority of the inactive pre-MPF present at the
time these extracts were made was in a pelletable form,
active MPF was present in both the soluble (HSS-2) and
insoluble (HSP-2) fractions.
Figure 5B shows a time course of the phosphorylation
status of CyclinB2 and Cdc25C followed in HSS-2 and HSP-2
separately and in HSS-2/HSP-2 recombined upon incuba-
tion at 21°C from 0 to 30 min. In recombined aliquots of
HSS-2/HSP-2 (Figure 5B, top), a full cycle of MPF activation
and inactivation occurred with phosphorylation of Cdc25C
reaching a peak at 20 min, before undergoing dephosphor-
ylation. The doublet band of Cyclin B2 shifted to favor the
upper phosphorylated form by 10 min and had degraded by
20 min. In contrast, in HSS-2 incubated alone (middle),
Cdc25C activated within 5 min of transfer to 21°C but failed
to inactivate, whereas the small amount of Cyclin B2
(present mainly as the activated upper isoform) remained
stable. In the HSP-2 (bottom), the Cdc25C was unable to
activate in the absence of the supernatant and CyclinB2
failed to degrade. These data indicate that the pelletable
Figure 4. Annulate lamellae are
enriched in HSP-2. TEM and neg-
ative staining were used to iden-
tify structures in the pelleted frac-
tions. (A) Image of HSP-1a,
showing mitochondria and some
putative ribosomal material. (B)
Image of HSP-1b, membranes
covered in ribosome-sized parti-
cles consistent with an enrich-
ment of ER. (C) Image of HSP-2,
containing granular material and
stacks of membranes containing
identifiable nuclear pore com-
plexes. The membranes have been
sectioned both transversely and
tangentially. Pore complexes
were also detected by negative
staining in HSP-2 from another
extract (D). Bars, 0.5 m in A–C
and 0.1 m in D.
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populations of Cdc25C and pre-MPF cannot activate in the
absence of a soluble component. In contrast, part of the MPF
activation-inactivation loop involving Cdc25C can occur in
the aqueous compartment of the egg, but without the pellet
components in the HSP-2 it cannot complete. Part of an
explanation for these observations may be that an inhibitor
of Cdc25C is present in the pellet, thus preventing activation
in this fraction.
MPF Shifts from the HSP-2 to the Supernatant upon
Activation
Comparison of CyclinB2 and Cdc25C distribution in extracts
prepared at slightly different times with respect to the ad-
vancement of the cell cycle allowed us to demonstrate that
MPF shifts from the pellet to the supernatant in parallel with
activation. The HSS-2 and HSP-2 from four different extracts
(Figure 5C, i–iv) were migrated in parallel and immuno-
blotted for Cdc25C and CyclinB2. The time taken for these
different extracts to undergo MPF activation at 21°C was
(lanes 3–7, equal loading was confirmed by Coomassie blue stain-
ing, our unpublished data). After electrophoretic transfer, different
molecular weight regions of the same blot were probed with the
antibodies indicated above each horizontal strip. Most of the Cy-
clinB2 and Cdc2 present in the initial LSS extract remained in the
supernatant (HSS-1) after high-speed centrifugation. The second
high-speed centrifugation pelleted most inactive Cdc25C (lower
arrow, hypophosphorylated form) and inactive, phosphorylated
Cdc2 (upper arrow in PSTAIR blot), together with most of the
CyclinB2, representing the pre-MPF predominant in these extracts
(lane 7). In contrast, the small amount of active MPF present in the
original prophase extracts was retained in the final soluble fraction
(HSS-2, lane 6), as indicated by the presence of CyclinB2 predomi-
nantly in the phosphorylated form (upper arrow) associated with
activating/activated MPF and the absence of the inactive Cdc2
isoforms. Multiply phosphorylated Cdc25C (upper arrow) was also
present in the HSS-2. (B) Cdc25C can activate in the supernatant
alone but not in the pellet alone. Volumes (30 l) of either recom-
bined HSS-2  HSP-2 or HSS-2 alone or HSP-2 alone were trans-
ferred to 21°C and aliquots were taken every 5–10 min for 30 min
(indicated at the bottom of the figure). A typical time course of
activation (phosphorylation and shift to the upper isoforms) and
inactivation (dephosphorylation and down shift on the gel) of
Cdc25C occurred 30 min in the recombined aliquots (top). Acti-
vation without inactivation was observed in the HSS-2 alone,
whereas no activation occurred in the HSP-2 alone. Approximate
relative molecular weights in kilodaltons are shown on the left. (C)
Activated forms of CyclinB2 shift from HSP-2 to HSS-2 during MPF
activation. The activation status of Cdc25C and presence of Cy-
clinB2 in HSS-2 and HSP-2 were compared in four different extracts
made at slightly different times in the cell cycle and designated i to
iv as indicated at the top of the figure. From analysis of MPF
activation in these extracts at 21°C (see text for details), we can
deduce that extract i was made before activation, extracts ii and iii
were made at the onset of activation, and extract iv was made
during the activation of MPF, as stated at the bottom of the figure.
The same region of a parallel gel stained with Coomassie blue is
shown to allow comparison of protein loading. Approximate rela-
tive molecular weights in kilodaltons are shown on the left. For each
extract i to iv paired samples of HSS-2 (left) and HSP-2 (right) were
loaded as indicated below the lanes. Irrespective of the degree of
MPF activation in these extracts, most of the faster migrating Cy-
clinB2 isoform, representing pre-MPF (A) and inactive Cdc25C is
pelleted into HSP-2.
Figure 5. (A) Pre-MPF and inactive Cdc25C preferentially pellet
into HSP-2. Immunoblots showing the different isoforms of MPF
and Cdc25C in prophase LSS and HSS-1 run on the same gel (lanes
1 and 2) and in the various high-speed fractions run on a second gel
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used retrospectively as an indication of the extracts’ cell
cycle state at the time each was made. Extract i was made
before activation had begun and reached peak activation at
40 min after transfer to 21°C. Extracts ii and iii were made at
the onset of activation and reached peak activity after 10
min, and extract iv was made during the activation phase of
MPF, such that it had already reached 90% of peak activa-
tion when it was fractionated.
In all four extracts the inactive form (lower band) of
Cdc25C pelleted in the HSP-2 (right-hand lane of each pair)
but increasingly activated (upper band) isoforms were
found in the HSS-2 (left-hand lane of each pair). Similarly,
inactive CyclinB2 was always sedimented in the HSP-2,
whereas CyclinB2 was increasingly detectable in the HSS-2
as the cell cycle progressed and invariably migrated as its
upper phosphorylated (active) form. The presence of the
upper form of CyclinB2 in both HSP-2 and HSS-2 became
more apparent in those extracts closest to full activation.
These comparisons thus revealed a clear correlation be-
tween the degree of MPF/Cdc25C activation in the eggs as
they advance into M phase and the appearance of activated
forms in the HSS-2 when fractionated. Furthermore, these
comparisons suggest that MPF activation occurs first in as-
sociation with the pelletable structures where active and
inactive forms of CyclinB2 are detected together. Taken
together, our analyses of MPF and Cdc25C compartmental-
ization in egg fractions indicate that MPF activation requires
both soluble and structural components and is coupled to
release from a pelletable fraction containing particulate ma-
terial and AL membranes.
CyclinB2 Associates with Annulate Lamellae in
Stage VI Oocytes
Studies from various cell types indicate that CyclinB-Cdc2
occupies distinct cellular compartments before mitosis. Be-
cause the only recognizable structures present in the HSP-2
were AL (see above), we wished to know whether the co-
fractionation of AL and pre-MPF in the HSP-2 reflected in
vivo association of these elements. Unfortunately, the Cy-
clinB antibodies available were not of high enough affinity to
allow EM immunolocalization on pelleted material. Instead,
we exploited the localization of characteristic AL in the
vegetal subcortex of immature (stage VI) Xenopus oocytes
(Terasaki et al., 2001) to perform colocalization studies at the
light microscope level. The size and opacity of the Xenopus
egg is prohibitive for clear visualization of deep structures
such as the nucleus; however, the first 10–20 m below the
cell surface where the AL lie is easily accessible to confocal
microscopy in both fixed and live eggs. Immature oocytes
are naturally arrested at prophase of meiosis and thus are at
an equivalent cell cycle state to the activated eggs used in the
extract fractionation experiments just described. We used
CyclinB2 as a marker for the distribution of pre-MPF be-
cause it is the major B type cyclin present in stage VI oocytes
(Kobayashi et al., 1991) and is almost exclusively present as
a complex with Cdc2 (Solomon et al., 1990; Ookata et al.,
1992).
The distribution of AL, the ER protein GRP94, and Cy-
clinB2 was first examined by a series of immunofluorescence
experiments on fixed oocytes (Figure 6) and then by micro-
injection of GFP-CyclinB2 into stage VI oocytes followed by
live imaging of the vegetal cortex (Figure 7). AL, which can
be clearly detected by the anti-NUP antibody used for West-
ern blot experiments, show up as islands of various shapes,
but mostly form long and narrow “cigars” ranging from 10
to 30 m in length and 3–5 m in width and depth (Figures
6, A and D, and 7E; Terasaki et al., 2001). Double labeling for
NUP and Grp94 (Figure 6, A and B) confirmed that the
NUP-stained islands were embedded within the ER network
(Figure 6C), consistent with the position of AL as an integral
part of the ER network (Bal et al., 1968; Kessel, 1992; Terasaki
et al., 2001). Strikingly, double labeling with anti-CyclinB2
and anti-NUP (Figure 6, D and E) revealed accumulations of
anti-CyclinB2 on the AL as well as in spots distributed
throughout the cytoplasm (see Figure 6F for overlay). The
extent of localization of CyclinB2 at annulate lamellae and
the amount of CyclinB2 on the AL was variable between
experiments. This variability may, in part, be due to slight
differences in fixation/processing or to the low affinity of the
anti-CyclinB2 antibody. Note that the incomplete overlap in
the anti-Nup and anti-CyclinB2 staining pattern would be
consistent with Cyclin association to AL through structures
other than pore components.
Examination of the distribution of a Xenopus CyclinB2-
GFP protein in live oocytes confirmed the CyclinB2–AL
association. A GFP-CyclinB2 mRNA was microinjected into
stage VI oocytes and imaged at regular intervals by confocal
microscopy. GFP fluorescence was first observed as islands
at the vegetal cortex 2 to 4 h after microinjection (Figure 7B),
strongly resembling the pattern and dimensions of the cigars
detected by NUP antibody in the same region (Figure 7E).
This pattern of CyclinB2-GFP was observed in three separate
experiments. A mRNA coding for nonconjugated GFP was
injected for comparison (Figure 7, C and D). The strongest
accumulation of GFP fluorescence was observed in a shal-
lower more cortical layer than that observed with CyclinB2-
GFP (compare Figure 7C with 7A). At deeper levels, equiv-
alent to those at which the AL are situated, some
fluorescence was visible as more diffuse islands (compare
Figure 7D with 7B). A group of the subcortical structures
decorated by the CyclinB2-GFP is shown at higher magnifi-
cation in Figure 7F and can be seen to be equivalent to the
AL stained with anti-NUP in Figures 6 and 7E. We thus
conclude that CyclinB2 associates with AL in live oocytes.
The AL-like pattern of GFP-CyclinB2 was more striking
and had a less spotty appearance than that obtained by
immunofluorescence in fixed oocytes. This difference may
reflect structural changes upon fixation and poor detection
by the antibody in immunofluorescence experiments, the
lower concentration of endogenous CyclinB2, and/or the
progression through meiosis in CyclinB2-GFP–expressing
oocytes. Nevertheless, the observed localization of CyclinB2
at AL by these two different approaches is a strong indica-
tion that some proportion of the CyclinB2-Cdc2 pool asso-
ciates with AL in prophase oocytes and that the cofraction-
ation of pre-MPF and AL observed in the HSP-2 made from
prophase activated eggs reflects an in vivo association.
DISCUSSION
MPF activation in both oocytes and fertilized eggs of Xeno-
pus has been shown to initiate locally within the animal
hemisphere (Masui, 1972; Rankin and Kirschner, 1997;
Pe´rez-Mongiovi et al., 1998) and to be stimulated by subcel-
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lular structures, including nuclei, centrosomes, and micro-
tubule asters (Gautier, 1987; Li et al., 1997; Iwashita et al.,
1998; Pe´rez-Mongiovi et al., 2000), which may act to accu-
mulate MPF and its regulators and/or other cellular com-
ponents involved in activation in the perinuclear region.
Despite these intriguing findings, relatively little attention
has been paid to the subcellular association of MPF and its
regulators in these cells. Immunofluorescence studies in Xe-
nopus have been limited to a low-resolution study showing
that CyclinB is concentrated in cortical and perinuclear rings
in toad oocytes (Sakamoto et al., 1998) as it is in Drosophila
(Raff et al., 1990). In this study, we revealed a cofractionation
of characteristic AL together with pre-MPF from high-speed
extracts of activated eggs. This finding prompted us to vi-
sualize CyclinB2 distribution in live and fixed oocytes,
which confirmed that MPF associates with AL. We have thus
provided evidence from complementary approaches that
MPF associates with nuclear membranes at the onset of M
phase. Note that we use the term “nuclear membranes” to
include the excess nuclear envelope components that exist as
cytoplasmic AL as well as the nuclear envelope proper. The
association of pre-MPF with nuclear membranes provides
an explanation for the influence of nuclei and centrosomes
on MPF activation. It may also favor the nuclear/cytoplas-
mic shuttling of active MPF derived from a localized pool (Li
et al., 1997; Yang et al., 1998; Hagting et al., 1999). Further-
more, the specific targeting of CyclinB-Cdc2 to the nuclear
envelope could facilitate the phosphorylation of nuclear en-
velope proteins, including nucleoporins, at mitosis neces-
sary to promote nuclear envelope breakdown.
Annulate Lamellae, Nuclear Envelopes, and MPF
Localization
AL are stacks of ER membranes containing a high density of
nuclear pores, thought to form from excess nuclear mem-
brane components, that have been described in a number of
different cells, including oocytes from various species as
well as rapidly proliferating cells. AL membranes are con-
tinuous with and embedded within the ER (this study, Fig-
ure 6, A—C; Kessel, 1992; Terasaki et al., 2001), and it is not
clear why they separate from the rest of the ER during
fractionation, although the high concentration of nuclear
pores is likely to significantly affect their density. AL accu-
mulate in interphase Xenopus egg extracts (Dabauvalle et al.,
1991; Meier et al., 1995) and disassemble in parallel with the
nuclear envelope at mitosis/meiosis (Cordes et al., 1996;
Imreh and Hallberg, 2000; Terasaki et al., 2001) and thus will
be maximally accumulated at the time we made our extracts,
favoring their identification in our study.
Figure 6. Detection of CyclinB2 at AL in stage VI oocytes. Confocal images of the vegetal cortex region of oocytes fixed and processed for
double immunofluorescence by using anti-Nup and anti-GRP94 (A and B) and anti-Nup and anti-CyclinB2 (D and E). Superimposed images
with anti-GRP94 or anti-CyclinB2 in green and anti-NUP in red are shown in C and F, respectively. Bars, 10 m.
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We were able to confirm that part of the MPF population
in the undisturbed cell colocalizes with AL by two indepen-
dent visualization methods applied to whole oocytes: im-
munofluorescence on fixed material and live imaging of
GFP-CyclinB2. Cyclin B2-GFP expressed in immature oo-
cytes localized to distinctive cigar-shaped structures located
close to the vegetal surface with the characteristics defined
for AL (Terasaki et al., 2001), whereas an anti-cyclin B2
antibody decorated equivalent structures in fixed eggs,
which we showed directly to be enriched in NUP proteins. It
would be very hard to demonstrate association of MPF with
the nuclear envelope in fertilized eggs because the tiny
nucleus is hard to locate, whereas excess nuclear membrane
components are dispersed throughout the volume of the
egg. Because oocytes are naturally arrested in prophase,
their cell cycle state is roughly equivalent to that of our
extracts, made 60 min after activation ,and AL are concen-
trated in a visually accessible place. The microscopy data
thus provide good evidence that the cofractionation of pre-
MPF and AL from extracts reflects genuine in vivo associa-
tion of these components at the onset of M phase; indeed, it
is remarkable that in spite of the fundamental differences
that exist between cells in the meiotic and mitotic state, we
find this identical association.
The association of pre-MPF with AL provides an expla-
nation for the stimulation of MPF activation by nuclei and
centrosomes and supports the suggestion that activation
initiates at the nucleus/centrosome (Masui, 1972; Gautier,
1987; Shinagawa et al., 1989; Iwao et al., 1993; Li et al., 1997;
Rankin and Kirschner, 1997; Iwashita et al., 1998; Pe´rez-
Mongiovi et al., 1998, 2000). For instance, centrosomal or
perinuclear concentration of AL stacks has been observed in
ascidians (Beckhelling, unpublished data; Roegiers et al.,
1999), insect oocytes (Rieder and Nowogrodzki, 1983), and
sea urchin eggs (Kallenbach, 1982). These observations may
help to explain the reported concentration of pre-MPF with
other organelles in the perinuclear and/or pericentriolar
region as well as to provide the basis for its association with
nuclei in yeast (Alfa et al., 1990; Audit et al., 1996). Reexam-
ination of published images shows association of CyclinB
with the nuclear envelope at the onset of mitosis in Drosoph-
ila embryos (Wakefield et al., 2000, supplementary material)
Figure 7. GFP-CyclinB2 localization to annulate lamellae in vivo. (A and B) An oocyte microinjected with CyclinB2-GFP mRNA and imaged
by confocal microscopy 4 h later from the vegetal side. A shows the vegetal cortical layer, whereas B is at the level of the subcortical AL. (C
and D) An oocyte microinjected with nonconjugated GFP mRNA. C shows the vegetal cortex, whereas D is a subcortical layer equivalent to
that in B. Note in D the fluorescence in the oocyte cortical rim that is not apparent with the GFP-CyclinB2 in B. E a confocal image of AL
labeled by immunofluorescence in a fixed oocyte by the anti-NUP antibody at the same magnification as A–D. Bars, 20 m. F is a higher
magnification image of islands labeled in B by the GFP-CyclinB2. Bar, 10 m.
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and subpopulations of Cyclin B1 and Cdc2 localized as a
perinuclear ring during interphase in HeLa cells (Bailly et al.,
1992; Pockwinse et al., 1997; Clute and Pines, 1999). These
patterns may have been overlooked because of the strong
localization of Cyclin B1 to centrosomes throughout inter-
phase (Bailly et al., 1992; Jackman et al., 1995) or microtu-
bules at mitosis (Jackman et al., 1995) and that of Cyclin B2
at the Golgi in the pericentriolar area (Jackman et al., 1995;
reviewed in Beckhelling et al., 2000; Ohi and Gould, 1999;
Pines, 1999). Furthermore, recent detailed observations of
Cyclin B distribution by immunofluorescence and Cyclin
B-GFP expression in prophase starfish oocytes has revealed
a clear association with the nuclear envelope (Terasaki, per-
sonal communication). Taken together, these observations
support the suggestion that concentration of MPF in the
perinuclear/pericentriolar area promotes MPF activation lo-
cally ahead of the rest of the cell (Beckhelling et al., 2000).
The nature of the association of pre-MPF with nuclear
membrane components and the mechanisms that may act to
concentrate these components around the centrosome re-
main to be dissected. Nuclear pores are huge complexes
containing up to 100 different polypeptides (Bagley et al.,
2000) that could provide potential links with pre-MPF itself
or associated regulatory molecules. Pericentriolar distribu-
tion of pore proteins or other nuclear envelope components
could be explained by their accumulation at microtubule
minus ends via a documented association with cytoplasmic
dynein (Reinsch and Karsenti, 1997; Beaudouin et al., 2002;
Salina et al., 2002).
Pre-MPF Is Insoluble and MPF Solubilizes upon
Activation
Our fractionation studies revealed a clear partitioning of pre-
MPF and inactive Cdc25C into a pelletable fraction, whereas
active MPF and active Cdc25C are found predominantly in the
cytosol. Both active and inactive forms of MPF can be detected
in the pellet depending upon the time of fractionation, suggest-
ing that activation occurs in the pellet and then active forms
shift to the supernatant. Other studies have also indicated that
the localization of the MPF complex changes in parallel with its
activation. A study in a Xenopus cell line showed that CyclinB1
shifts from a perinuclear site in prophase to a centrosomal and
finally mitotic spindle location as the cycle progressed
(Charrasse et al., 2000). Analysis of MPF activity in fractionated
human cells demonstrated that H1 kinase activates first in
association with centrosomes, then in the cytoplasm, and last in
the nucleus (De Souza et al., 2000). Similarly, pre-MPF was
found in a detergent-resistant fraction of human cells, whereas
soluble MPF had high kinase activity, leading to the suggestion
that active and inactive forms of MPF exist in equilibrium at the
interface of structural/soluble cytoplasmic compartments
(Bailly et al., 1992).
In Xenopus egg extracts, Cyclin B1/Cdc2 has previously been
shown to pellet after high-speed centrifugation (Leiss et al.,
1992). The conditions in that study would have pelleted all the
material that we find distributed between HSP-1a, -1b, and
HSP-2 in our protocol, thus making it difficult to identify which
structures associated with these molecules. It is nevertheless
clear that the major constituents of pre-MPF, CyclinB1/Cdc2
(Leiss et al., 1992), and CyclinB2/Cdc2 (our study) as well as
inactive Cdc25C, are insoluble. Furthermore, their release from
associated structures leads to, or is concomitant with, activa-
tion to MPF. Simply adding CyclinB90 to a cytosol where free
Cdc2 exists, does not activate H1 kinase (Leiss et al., 1992),
suggesting that the presence of some other component of the
pellet is critical for MPF activation.
Concluding Remarks
The results presented herein have uncovered the unexpected
participation of nuclear membranes in activation of MPF.
Associations for AL with a variety of molecular complexes
have been reported; for instance, AL have been shown to
colocalize with P granule material, associated with germ cell
determination in Caenorhabditis elegans embryos (Pitt et al.,
2000). In another example, SUMO-1 protease SENP2 associ-
ates with NUP153 of the nuclear pore in humans (Hang and
Dasso, 2002), as does a related protease with NUP42 in yeast
(Takahashi et al., 2000). The presence of AL at the vegetal
cortex of the large Xenopus oocyte, and their reorganization
at M phase that mirrors that of the nuclear envelope (Ter-
asaki et al., 2001), provides an excellent opportunity to fur-
ther explore interaction of nuclear membranes with biolog-
ically important macromolecules in vivo. In particular a
localization study of the various regulators of MPF such as
Wee1, Myt1, the CDK inhibitor, Polo kinase, CyclinA-Cdc2,
Pin1, CAK, and suc1 may further illuminate the basis of
localized MPF regulation in the perinuclear region.
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